Sanofi and Regeneron report phase 2 data for potential first-in-class lipid-lowering PCSK9 antibody
- Details
- Category: Sanofi

US court denies preliminary injunction application against the FDA and dismisses AstraZeneca's lawsuit
- Details
- Category: AstraZeneca

Roche's Herceptin given by subcutaneous injection offers greater convenience and reduces costs
- Details
- Category: Roche

UK court finds SEROQUEL XR® formulation patent invalid
- Details
- Category: AstraZeneca

Abbott selects AbbVie as new name for future research-based pharmaceutical company
- Details
- Category: Abbott

Remaining TC-5214 Phase III efficacy studies do not meet endpoint
- Details
- Category: AstraZeneca

Sanofi to Acquire Pluromed, Inc., Expanding its Presence in Biosurgery
- Details
- Category: Sanofi

More Pharma News ...
- GlaxoSmithKline provides further update on divestment of non-core OTC brands
- Roche receives request for additional information from the Federal Trade Commission
- AstraZeneca files lawsuit against the FDA
- Pfizer's Prevnar 13® shown to be immunogenic in older children and adolescents
- Schwartz Center Receives $500,000 Grant from the Amgen Foundation
- Roche Annual General Meeting 2012
- GSK announces submissions for two influenza vaccines